Targeted Oncology

NCCN Now Backs CSF Genomic Testing in Gliomas When Biopsy Isn't Possible

NCCN now endorses CSF-based profiling for biopsy-infeasible HGG/GBM to enable molecular characterization required for ...

Belay Announces Update to NCCN Guidelines to Recommend CSF-based Genomic Profiling in Biopsy Infeasible High-Grade Gliomas

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) regarding characterization and treatment of central ...
Nature

Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections

Metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) is an agnostic method for broad-based diagnosis of central nervous system (CNS) infections. Here we analyzed the 7-year ...
Medical Xpress

Study finds the timing of CSF biomarker divergence for Alzheimer disease, normal cognition varies

Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before ...
Nature

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

Intramedullary spinal cord tumors display considerable heterogeneity, manifesting distinct survival times depending on varied pathological classifications 1,2,3. Typically, patients undergo imaging, ...
technologynetworks

Multi-Analyte Cerebrospinal Fluid Test Accurately Detects Brain Cancer

A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers ...